Zusammenfassung
Sorgfältige Risiko-Nutzen-Bewertung und gültige Einwilligung nach Aufklärung dienen dem Wohl des Patienten, dem Schutz bzw. der Schadensvermeidung und der Achtung der Selbstbestimmung des Patienten. Dies wird mit Studien zur Früherfassung und -intervention von Vor- und Frühstadien psychischer Krankheit und placebokontrollierten Prüfungen, mit der therapeutischen Fehlwahrnehmung bei Prüfungen und dem Umgang mit Zufallsbefunden bei Reihenuntersuchungen exemplifiziert. Empfohlen werden eine 3-stufige Validierung der Risiko-Nutzen-Bewertung und ein Verständnis der Aufklärung des Patienten nicht nur als dessen Entscheidungsgrundlage, sondern auch als vertrauensfördernde Maßnahme.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Appelbaum PS, Roth LH, Lidz CW (1982) The therapeutic misconception: Informed consent in psychiatric research. Internat J Law Psychiatry 5:319–329
Appelbaum PS, Lidz CW (2008) Re-evaluating the therapeutic misconception: response to Miller and Joffe. Kennedy Inst Ethics J 16:367–373
Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller HJ (2003) Placebo-controlled studies in depression: necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253:22–28
Benkert O, Maier W (1990) The Necessity of Placebo Application in Psychotropic Drug Trials. Pharmacopsychiat 23:203–205
Carpenter WT Jr, Appelbaum PS, Levine RJ (2003) The Declaration of Helsinki and Clinical Trials: A Focus on Placebo- Controlled Trials in Schizophrenia. Am J Psychiatry 160:356–362
Corcoran C, Malaspina D, Hercher L (2005) Prodromal interventions for schizophrenia vulnerability: the risks of being »at risk«. Schizophrenia Research 73:173–184
Conus P, Ward J, Lucas N, Cotton S, Yung AR, McGorry PD (2010) Characterisation of the prodrome to a first episode of psychotic mania: Results of a retrospective study. J Affect Disorders 124:341–345
Cornblatt BA, Lencz T, Kane JM (2001) Treatment of the schizophrenia prodrome: is it presently ethical? Schizophr Res 51:31–38
Emanuel EJ, Miller FG (2001) The Ethics of Placebo-Controlled Trials – A Middle Ground. N Engl J Med 345:915–919
EMEA (2002) Note for Guidance on Clinical Investigation of Medicinal Products in the Treatment of Depression. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003526.pdf. Zugegriffen: 3. September 2011
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J (2010) Antidepressant Drug Effects and Depression Severity: A Patient-Level Metaanalysis. JAMA 303:47–53
Garattini S, Bertelé V (2007) Non-inferiority trials are uethical because they disregard patients' interests. Lancet 370:1875–1877
Garattini S, Bertele V, Bassi LL (2003) How can research ethics committees protect patients better? BMJ 326:1199–1201
Häfner H, Maurer K (2006) Early detection of schizophrenia: current evidence and future perspectives. World Psychiatry 5:130–138
Helmchen H (2005) Ethische Implikationen placebokontrollierter Prüfungen von Psychopharmaka. Nervenarzt 76:1319–1329
Illes J (2010) Empowering brain science with neuroethics. The Lancet 376:1294–1295
Illes J, Borgelt E (2009) Brain imaging: Incidental findings: in practice and in person. Nat Rev Neurol 5:643–644
Illes J, Chin VN (2008) Bridging Philosophical and Practical Implications of Incidental Findings in Brain Research. J Law Med Ethics 36:298–304
Illes J, Kirschen MP, Edwards E, Bandettini P, Cho MK, Ford PJ, Glover GH, Kulynych J, Macklin R, Michael DB, Wolf SM, Grabowski T, Seto B (2008) Practical approaches to incidental findings in brain imaging research. Neurology 70:384–390
Kimmelman J (2007) The therapeutic misconception at 25: treatment, research, and confusion. Hastings Cent Rep 37:36–42
Klosterkoetter J, Schultze-Lutter F (2010) Prevention and early treatment. In: Helmchen H, Sartorius N (Hrsg) Ethics in Psychiatry. Springer, Dordrecht, S 235–262
Lancet Editorial (2009) Teaching responsible conduct of research. Lancet 374:1568
Lidz CW, Appelbaum PS, Grisso T, Renaud M (2004) Therapeutic misconception and the appreciation of risks in clinical trials. Internat J Law Psychiatry 58:1689–1697
Maclean A (2009) Autonomy, Informed Consent and Medical Law. Cambridge University Press, New York
Miller FG, Joffe S (2006) Evaluating the therapeutic misconception. Kennedy Inst Ethics J 16:353–366
Morris Z (2009) Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 339:b3016
Propping P (2010) Genetics – Ethical Implications of Research, Diagnostics and Counseling. In: Helmchen H, Sartorius N (Hrsg) Ethics in Psychiatry. Springer, Dordrecht,S 459–486
Shaw RL, Senior C, Peel E, Cooke R, Donnelly LS (2008) Ethical Issues in Neuroimaging Health Research. J Health Psychol 13:1051–1059
Went L (1990) Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genetics 27:34–38
Wong C, Davidson L, Anglin D, Link B, Gerson R, Malaspina D, McGlashan T, Corcoran C (2009) Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis. Early Intervention in Psychiatry 3:108–115
Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E, Phillips LJ, Bechdolf A, Buckby J, McGorry PD (2008) Validation of «prodromal” criteria to detect individuals at ultra high risk of psychosis: 2-year follow-up. Schizophr Res 105(1–3):10–7
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Helmchen, H. (2012). Zwei ethische Grundvoraussetzungen psychiatrischer Forschung. In: Schneider, F. (eds) Positionen der Psychiatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25476-5_42
Download citation
DOI: https://doi.org/10.1007/978-3-642-25476-5_42
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25475-8
Online ISBN: 978-3-642-25476-5
eBook Packages: Medicine (German Language)